MIC27 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MIC27; AWRI1631_142180; MICOS complex subunit MIC27
Target Names
MIC27
Uniprot No.

Target Background

Function
MIC27 Antibody is a component of the MICOS complex. This complex is a large protein assembly located within the mitochondrial inner membrane. The MICOS complex plays essential roles in maintaining crista junctions, ensuring the integrity of the inner membrane architecture, and facilitating the formation of contact sites with the outer membrane.
Protein Families
Apolipoprotein O/MICOS complex subunit Mic27 family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What are the common applications for MIC27 antibodies in research?

MIC27 antibodies are commonly employed in several research techniques:

  • Western blot analysis - For detecting MIC27 protein levels in cell or tissue lysates

  • Immunofluorescence/immunohistochemistry - For visualizing MIC27 localization

  • Immunoprecipitation - For studying protein-protein interactions

  • STED super-resolution nanoscopy - For detailed visualization of MIC27 distribution in mitochondria

Methodologically, researchers should validate antibody specificity using appropriate controls. Based on published studies, MIC27 antibodies have been successfully used to confirm protein knockout in CRISPR-Cas-generated cell lines and to examine the characteristic punctate distribution pattern of MIC27 along mitochondria using super-resolution microscopy .

How can I validate the specificity of a MIC27 antibody?

Proper validation of MIC27 antibodies is essential for reliable experimental results. An effective validation approach includes:

  • Testing the antibody on MIC27 knockout cells (negative control) - Studies have used CRISPR-Cas-generated MIC27 knockout HAP1 cells for this purpose

  • Confirming single band detection at the expected molecular weight (~27 kDa) in Western blots

  • Performing peptide competition assays

  • Checking for co-localization with mitochondrial markers in immunofluorescence

  • Comparing staining patterns with published data showing the characteristic MICOS complex punctate distribution

A methodologically sound validation should include both positive and negative controls. MIC27 knockout cells have been generated using CRISPR-Cas targeting exon 3 of the MIC27 gene (also known as APOOL), resulting in frame-shift mutations and premature termination of transcription .

What are the optimal conditions for using MIC27 antibodies in Western blot analysis?

For optimal Western blot results with MIC27 antibodies:

  • Sample preparation:

    • Extract mitochondrial fractions to enrich for MIC27

    • Use appropriate lysis buffers containing protease inhibitors

  • Gel electrophoresis:

    • Run 10-15% SDS-PAGE gels

    • Load 20-50 μg of total protein per lane

  • Transfer conditions:

    • Semi-dry or wet transfer at 100V for 1 hour or 30V overnight

    • PVDF membranes are preferable for mitochondrial proteins

  • Blocking and antibody incubation:

    • Block with 5% non-fat milk or BSA

    • Incubate with MIC27 primary antibody at 1:1000 dilution (optimize based on specific antibody)

    • Use overnight incubation at 4°C for best results

  • Detection:

    • Use HRP-conjugated secondary antibodies and ECL detection systems

    • Expected band size: approximately 27 kDa

This methodological approach has been successfully employed in studies examining MIC27 expression in various cell types, including the analysis of MIC26 and MIC27 single and double knockout HAP1 cells .

How should I optimize immunofluorescence protocols for MIC27 antibodies?

For optimal immunofluorescence results with MIC27 antibodies:

  • Fixation and permeabilization:

    • 4% paraformaldehyde (10-15 minutes)

    • Permeabilize with 0.2% Triton X-100 (10 minutes)

  • Blocking:

    • 5% BSA or normal serum (1 hour at room temperature)

  • Antibody incubation:

    • Primary antibody: 1:100-1:500 dilution (optimize for specific antibody)

    • Incubate overnight at 4°C

    • Secondary antibody: 1:500-1:1000 for 1 hour at room temperature

  • Co-staining recommendations:

    • MitoTracker or TOMM20 antibody for mitochondrial network visualization

    • MIC60 or MIC10 for MICOS complex co-localization studies

  • Imaging considerations:

    • Confocal microscopy is recommended for standard visualization

    • STED super-resolution nanoscopy is ideal for detailed analysis of MIC27's punctate distribution along mitochondria

When analyzing results, expect to see a punctate staining pattern arranged in a rail-like fashion along mitochondria, similar to what has been observed for core MICOS subunits like MIC60 and MIC10 .

How can I use MIC27 antibodies to study the interaction between MIC27 and cardiolipin?

To investigate MIC27-cardiolipin interactions, researchers can employ several advanced approaches:

  • Co-immunoprecipitation with MIC27 antibodies:

    • Use crosslinking reagents to stabilize protein-lipid interactions

    • Extract with gentle detergents that preserve lipid interactions

    • Analyze precipitated lipids using mass spectrometry

  • Liposome binding assays:

    • Prepare liposomes with varying cardiolipin content

    • Incubate with recombinant MIC27

    • Use MIC27 antibodies for detection in pelleting assays

  • Proximity ligation assays (PLA):

    • Use MIC27 antibodies and lipid-binding probes

    • Quantify interaction signals in fixed cells

Research has shown that MIC27 and MIC26 cooperatively regulate cardiolipin levels, and their deletion leads to reduced cardiolipin content in mitochondria . The methodological approach should focus on detecting these alterations and how they relate to mitochondrial function. Studies have demonstrated that overexpression of cardiolipin synthase (CRLS1) in MIC26/MIC27 double knockout cells can restore the stability of respiratory chain complexes and supercomplexes , suggesting a direct link between these proteins and cardiolipin metabolism.

How do I analyze potential differences in MIC27 distribution in various disease models using antibody-based techniques?

For analyzing MIC27 distribution in disease models:

  • Experimental design considerations:

    • Select appropriate disease models (cell lines, animal models, patient samples)

    • Include matched controls

    • Consider time-course experiments for progressive conditions

  • Quantitative immunofluorescence approach:

    • Use consistent imaging parameters

    • Employ STED super-resolution nanoscopy for detailed analysis

    • Quantify parameters such as:

      • Signal intensity

      • Distribution pattern (punctate vs. diffuse)

      • Co-localization with other MICOS components

      • Distance between MIC27 punctae

  • Complementary techniques:

    • Western blot for total protein level changes

    • Blue-native PAGE for analyzing MIC27 incorporation into MICOS complex

    • Electron microscopy for cristae morphology assessment

  • Data analysis methods:

    • Use image analysis software for quantification

    • Perform statistical comparison across multiple samples

    • Correlate MIC27 distribution changes with functional parameters

This methodological approach has been applied in research comparing normal and knockout cell lines, revealing that MIC27 shows a characteristic punctate staining pattern similar to other MICOS components, which is disrupted in pathological conditions .

How can MIC27 antibodies be used to study the assembly and stability of the MICOS complex?

To investigate MICOS complex assembly and stability using MIC27 antibodies:

  • Co-immunoprecipitation studies:

    • Use MIC27 antibodies for immunoprecipitation

    • Analyze co-precipitated MICOS components by Western blot

    • Compare results under different conditions (e.g., stress, metabolic changes)

  • Blue native PAGE analysis:

    • Extract mitochondria with mild detergents

    • Separate native complexes on gradient gels

    • Detect MIC27 and other MICOS components by Western blot

    • Analyze complex size and composition

  • Complexome profiling approach:

    • Combine blue native PAGE with mass spectrometry

    • Quantify protein abundances across gel slices

    • Generate heat maps of protein migration patterns

  • Pulse-chase experiments:

    • Track newly synthesized MIC27 incorporation into MICOS

    • Use antibodies to immunoprecipitate at different time points

  • Super-resolution microscopy:

    • Apply STED nanoscopy to visualize MICOS subcomplex organization

    • Use multi-color imaging with antibodies against different subunits

Research has shown that MIC26 and MIC27 assemble late into the MICOS complex and are dispensable for the stability and integration of remaining MICOS subunits . Studies using complexome profiling, STED nanoscopy, and blue-native gel electrophoresis have demonstrated that while deletion of MIC26 and MIC27 affects cristae morphology, it does not disrupt the core MICOS architecture .

How can I resolve discrepancies between Western blot and immunofluorescence results when using MIC27 antibodies?

When facing discrepancies between Western blot and immunofluorescence results:

  • Methodological considerations:

    • Antibody epitope accessibility may differ between denatured (Western) and native (IF) conditions

    • Different fixation methods may alter epitope recognition

    • Post-translational modifications might affect antibody binding

  • Systematic troubleshooting approach:

    • Test multiple antibodies targeting different MIC27 epitopes

    • Validate with independent techniques (e.g., mass spectrometry)

    • Use MIC27 knockout controls to confirm specificity

    • Consider native vs. denatured protein detection differences

  • Potential explanations for common discrepancies:

    • Western blot positive, IF negative: Epitope masked in native conformation

    • IF positive, Western blot negative: Low abundance or extraction issues

    • Different subcellular patterns: Potential isoforms or processing

  • Validation strategies:

    • Express tagged MIC27 as a positive control

    • Use siRNA knockdown for partial reduction

    • Compare results with published data on MIC27 distribution patterns

Research has demonstrated that MIC27 shows specific punctate staining in immunofluorescence that resembles the characteristic MICOS-specific pattern, appearing similar to that of MIC60 and MIC10 . In Western blot analysis, MIC27 should appear as a specific band at approximately 27 kDa .

What controls should I include when analyzing the effects of MIC27 knockout or knockdown using antibodies?

For rigorous analysis of MIC27 knockout or knockdown effects:

  • Essential experimental controls:

    • Positive control: Wild-type cells or tissues expressing normal levels of MIC27

    • Negative control: Validated MIC27 knockout cells (e.g., CRISPR-Cas9 generated)

    • Rescue control: Re-expression of MIC27 in knockout cells

    • Treatment control: Non-targeting siRNA for knockdown experiments

  • Validation of knockout/knockdown efficiency:

    • Western blot quantification of MIC27 protein levels

    • qRT-PCR for mRNA level verification

    • Immunofluorescence confirmation of protein absence

  • Phenotype analysis controls:

    • Comparison with MIC26 single knockout and MIC26/MIC27 double knockout

    • Assessment of other MICOS subunit levels and localization

    • Mitochondrial function parameters (respiration, membrane potential)

  • Rescue experiment design:

    • Re-express MIC27 at physiological levels

    • Include non-functional MIC27 mutants as controls

    • Assess restoration of phenotypes (cristae structure, respiration, complex stability)

Research has shown that single knockout of MIC27 produces milder phenotypes compared to MIC26/MIC27 double knockout, highlighting their cooperative functions . Studies have demonstrated that simultaneous re-expression of MIC26 and MIC27 in double knockout cells can rescue the stability of respiratory chain complexes and improve mitochondrial respiration .

How can MIC27 antibodies be applied in studies examining the relationship between MICOS complex dysfunction and respiratory chain supercomplex stability?

To investigate links between MICOS dysfunction and respiratory chain supercomplex stability:

  • Experimental design approach:

    • Compare MICOS subunit knockout models (particularly MIC26/MIC27 DKO)

    • Analyze respiratory chain supercomplex assembly using blue native PAGE

    • Perform complexome profiling to detect subtle changes in complex composition

    • Measure functional consequences (respiration, ATP production)

  • Methodological techniques:

    • Blue native PAGE followed by Western blotting with antibodies against:

      • MIC27 and other MICOS components

      • Subunits of complex I (NDUFS1/2)

      • Subunits of complex III (UQCRC2)

      • Subunits of complex IV (MTCO1)

    • Complexome profiling for comprehensive analysis of protein complex assembly

    • Oxygen consumption measurements to assess functional impact

  • Data analysis considerations:

    • Quantify supercomplex/individual complex ratios

    • Correlate with cardiolipin levels

    • Assess F₁ subunit association with F₁F₀-ATP synthase complex

Research has demonstrated that MIC26 and MIC27 double knockout cells show drastically reduced levels of individual respiratory complexes and their higher associations into supercomplexes . This phenotype can be rescued by overexpression of cardiolipin synthase (CRLS1) , suggesting a mechanistic link between MICOS function, cardiolipin levels, and respiratory chain supercomplex stability.

What are the considerations for using MIC27 antibodies in conjunction with super-resolution microscopy techniques?

For optimal use of MIC27 antibodies in super-resolution microscopy:

  • Technical considerations:

    • Primary antibody selection:

      • Use high-affinity, monospecific antibodies

      • Validate specificity in knockout cells

      • Consider directly conjugated primary antibodies for STORM

    • Secondary antibody selection:

      • Use F(ab')₂ fragments for smaller size

      • Select bright, photostable fluorophores (Alexa 647, Atto 647N, Atto 488)

    • Sample preparation:

      • Optimize fixation (4% PFA + 0.1-0.2% glutaraldehyde)

      • Use thin sections (≤10 μm) for best results

      • Mount in appropriate medium (different for STED vs. STORM/PALM)

  • STED nanoscopy-specific considerations:

    • Resolution capability: 30-50 nm lateral resolution

    • Well-suited for visualizing MIC27's punctate distribution pattern

    • Requires photostable dyes with good stimulated emission properties

    • Good for multi-color imaging of MICOS components

  • STORM/PALM considerations:

    • Resolution capability: 10-25 nm lateral resolution

    • Requires special buffers and photo-switchable fluorophores

    • Better for quantitative analysis and precise distance measurements

    • More challenging for multi-color imaging

  • Data analysis approaches:

    • Quantify the spacing between MIC27 punctae

    • Measure co-localization with other MICOS components

    • Compare distribution patterns between normal and pathological conditions

Research using STED super-resolution nanoscopy has revealed that MIC27 shows a characteristic punctate staining pattern arranged in a regular rail-like fashion similar to core MICOS subunits like MIC60 and MIC10 , providing important insights into its role in cristae organization.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.